Resona Asset Management’s AbbVie ABBV Stock Holding History

Resona Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$122M	Buy	565,408 +10,331	+2%	+$2.29M	0.61%	23
2025 Q4	$127M	Sell	555,077 -24,330	-4%	-$5.54M	0.61%	21
2025 Q3	$133M	Sell	579,407 -34,342	-6%	-$6.99M	0.63%	21
2025 Q2	$114M	Buy	613,749 +24,927	+4%	+$4.63M	0.56%	28
2025 Q1	$123M	Buy	588,822 +42,266	+8%	+$8.22M	0.71%	22
2024 Q4	$97.1M	Sell	546,556 -23,833	-4%	-$4.38M	0.57%	27
2024 Q3	$112M	Sell	570,389 -8,469	-1%	-$1.58M	0.65%	23
2024 Q2	$99.1M	Sell	578,858 -26,792	-4%	-$4.44M	0.6%	24
2024 Q1	$110M	Buy	+605,650	New	+$104M	0.66%	24

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Resona Asset Management's ABBV Position: Q1 2026 in Review

Resona Asset Management increased its AbbVie (ABBV) stake by 1.9% in Q1 2026, buying an estimated $2.29M and bringing the position to 565,408 shares worth $122M. The position accounts for 0.61% of the portfolio, ranked #23.

Resona Asset Management first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $133M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Resona Asset Management held 565,408 shares of AbbVie worth $122M as of Q1 2026.
Resona Asset Management bought 10,331 AbbVie shares in Q1 2026, an estimated $2.29M.
AbbVie made up 0.61% of Resona Asset Management's portfolio in Q1 2026, its #23 holding.
Resona Asset Management first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
Resona Asset Management's AbbVie position peaked at $133M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Resona Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.